Maxim Group analyst Jason McCarthy downgrades Synaptogenix (NASDAQ:SNPX) from Buy to Hold.
Citigroup Maintains Neutral on Match Group, Lowers Price Target to $54
Citigroup analyst Ygal Arounian maintains Match Group (NASDAQ:MTCH) with a Neutral and lowers the price target from $55 to $54.